The open study for the effects of mosapride citrate on gastric ulcer healing after endoscopic submucosal disection.

The open study for the effects of mosapride citrate on gastric ulcer healing after endoscopic submucosal disection. - The effect of mosapride on ESD-induced gastric ulcer.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003747

Enrollment

Registered

2010-06-14

Start date

2010-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric ulcer

Interventions

Omeprazole 20mg once per day 1 month Omeprazole 20mg once per day + Mosapride citrate 5mg 3 times per day 1 month

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Men and women aged 20 or over,and under 80. Patients received endoscopic submucosal disection for early gastric cancer. Patients gave consent in writing.

Exclusion criteria

Exclusion criteria: Patients who had received gastrectomy. Patients who have a history of a previous drug allergy. Patients with serious comorbidities. Patients considered inappropriate by the responsible doctor.

Design outcomes

Primary

Measure	Time frame
gastric ulcer area	—

Secondary

Measure	Time frame
blood concentration of omeprazole	—

Countries

Japan

Contacts

Public ContactTomohisa Takagi

Kyoto Prefectural University of Medicine Gastroenterology

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026